Business
The Coretec Group Releases Shareholder Letter Highlighting the CHS Commercialization Timeline, Evonik Partnership and Customer Updates
The Coretec Group Releases Shareholder Letter Highlighting the CHS Commercialization Timeline, Evonik Partnership and Customer Updates.
About this update from The Coretec Group Inc.
[{"type":"text","content":"ANN ARBOR, MI / ACCESSWIRE / November 2, 2020 / The Coretec Group, Inc., (OTCQB:CRTG) ("Coretec"), a company developing a portfolio of silicon-based materials utilizing Cyclohexasilane ("CHS") to pursue commercial development of products in energy-focused verticals today issued a letter from CEO Michael Kraft to its shareholders:To Coretec's shareholders and customers:First of all, we'd like to extend a big thank you for your ongoing support and interest. The Coretec team has continued to make strides in our promise to deliver our liquid silicon, Cyclohexasilane (CHS) to market. We're now just a few months away from having a physical product on-hand and available for pilot testing by our customers.The progress doesn't stop there, however, as we're also getting CHS in the hands of companies that can leverage its unique properties to create next generation technologies in energy-focused verticals - bringing us even closer to experiencing the impact of CHS. To provide transparency as Coretec nears these milestones, we'd like to share these exciting updates with you.First, the supply partnership we entered into with Evonik just a few months ago is on schedule to deliver the initial 50g CHS samples by January 2021. We have been hands-on in our collaborative efforts, staying in constant contact with Evonik to follow progress and keep pace with our projected timeline. Process development is producing positive results, further validating our position that this is an efficient and scalable program that can become commercially viable. This is great news!As we near the commercialization milestone, we have created a plan and process for handling CHS here in Ann Arbor, MI where Coretec USA service and support is headquartered. Through our partnership with Evonik and manufacturing in Germany, we can supply CHS worldwide with an initial focus on the USA and Europe where a majority of our customer interest, design, and product development efforts originate.Second, we continue to take steps to acquire customers and establish partnerships. We have received significant interest from numerous customers in core markets spanning semiconductor, silicon anode Li Ion battery, and LED. I am especially pleased to have announced the partnership with Theion, where CHS is a key material in creating a battery that w...